| The role of WT1 in oncogenesis: tumor suppressor or oncogene?. | None |
| Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein. | None |
| Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein. | None |
| A tumor suppressor and oncogene: the WT1 story. | None |
| WT1 expression is induced by oncogenic signalling from BCR/ABL1. WT1 contributes to resistance against apoptosis induced by imatinib. | None |
| HtrA2, taming the oncogenic activities of WT1. | None |
| Wilms tumours: about tumour suppressor genes, an oncogene and a chameleon gene. | None |
| Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. | None |
| Both isoforms of the EWS/WT1 fusion protein can function as an oncogene in desmoplastic small round cell tumors. | None |
| The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts. | None |
| Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. | None |
| In this review, WT1 is a master regulator of organ development, a tumor suppressor and an oncogene. | None |
| WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene. | None |
| Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. | None |
| Multiple studies provide evidence that WT1 plays a significant role in a variety of cancers occurring mainly in childhood and adolescence, but with involvement in some adult cancers. Also, Wt1 has a tumor suppressive function and oncogenic properties as well. | None |
| we report that CUG initiation site for WT1 protein synthesis (CUG)-translated WT1 (cugWT1), an N-terminally extended form of canonical AUG initiation site for WT1 protein synthesis (AUG)-translated WT1 (augWT1), was overexpressed in most cancer cell lines and cancer tissues and functioned as an oncogene | None |
| Chromosome translocation-mediated conversion of a tumor suppressor gene into a dominant oncogene: fusion of EWS1 to WT1 in desmoplastic small round cell tumors. | None |
| The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct. | None |
| The Wilms tumor 1 gene: oncogene or tumor suppressor gene?. | None |
| The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. | None |